上海：推动人工智能技术与医药全产业链融合，加快人工智能药物发现与设计系统应用

Core Viewpoint - The Shanghai Municipal Government has issued measures to promote the high-quality development of the pharmaceutical industry through comprehensive reforms in drug and medical device regulation, emphasizing the digital transformation of the industry [1] Group 1: Digital Transformation in Pharmaceutical Industry - The measures aim to advance the digital transformation of the pharmaceutical industry by integrating artificial intelligence technology across the entire industry chain [1] - There is a focus on accelerating the application of AI drug discovery and design systems, as well as empowering research and development with large AI models [1] - Production enterprises are encouraged to adopt intelligent systems for smart manufacturing, laboratory management, and execution to build digital, scalable, and branded companies [1] Group 2: Vaccine and Blood Product Production - Vaccine production enterprises in Shanghai are encouraged to construct and upgrade production lines while strictly implementing information technology in the production inspection process [1] - Blood product companies are urged to establish an information system that covers the entire process from plasma collection to production and inspection, ensuring traceability [1] Group 3: Supply Chain Collaboration - Pharmaceutical distribution companies are encouraged to build collaborative platforms for supply chain digitalization [1] - The promotion of smart warehousing and scheduling is highlighted to enhance electronic data sharing and application across the supply chain [1]